Läkemedel 2026 del 2

Deadline:4 May 2026, 21:59

Contract award

Estimated value
SEK 99,000,000
Contract type
Framework agreement
Duration
01/09/2026 - 31/08/2028
Renewals
01/09/2028 - 31/08/2029
01/09/2029 - 31/08/2030
Bidders
Awarded bidders
Name
Biocon Biologics Ireland Limited
Grunenthal Sweden AB
Øresund Pharma ApS
Celltrion Sweden AB

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.